These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 32118586)

  • 1. The multifaceted role of ischemia/reperfusion in sickle cell anemia.
    Hebbel RP; Belcher JD; Vercellotti GM
    J Clin Invest; 2020 Mar; 130(3):1062-1072. PubMed ID: 32118586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemia-reperfusion injury in sickle cell anemia: relationship to acute chest syndrome, endothelial dysfunction, arterial vasculopathy, and inflammatory pain.
    Hebbel RP
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):181-98. PubMed ID: 24589261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
    Hebbel RP; Osarogiagbon R; Kaul D
    Microcirculation; 2004 Mar; 11(2):129-51. PubMed ID: 15280088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle red cell-endothelium interactions.
    Kaul DK; Finnegan E; Barabino GA
    Microcirculation; 2009 Jan; 16(1):97-111. PubMed ID: 18720225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice.
    Kaul DK; Liu XD; Choong S; Belcher JD; Vercellotti GM; Hebbel RP
    Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H293-301. PubMed ID: 15001449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice.
    Kaul DK; Hebbel RP
    J Clin Invest; 2000 Aug; 106(3):411-20. PubMed ID: 10930444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of Sickle Cell Disease.
    Sundd P; Gladwin MT; Novelli EM
    Annu Rev Pathol; 2019 Jan; 14():263-292. PubMed ID: 30332562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle red cell microrheology and sickle blood rheology.
    Ballas SK; Mohandas N
    Microcirculation; 2004 Mar; 11(2):209-25. PubMed ID: 15280093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade.
    Solovey A; Somani A; Belcher JD; Milbauer L; Vincent L; Pawlinski R; Nath KA; Kelm RJ; Mackman N; O'Sullivan MG; Gupta K; Vercellotti GM; Hebbel RP
    Am J Hematol; 2017 Nov; 92(11):1119-1130. PubMed ID: 28699284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell anemia as an inflammatory disease.
    Platt OS
    J Clin Invest; 2000 Aug; 106(3):337-8. PubMed ID: 10930436
    [No Abstract]   [Full Text] [Related]  

  • 11. Inflammatory mediators of endothelial injury in sickle cell disease.
    Hoppe CC
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):265-86. PubMed ID: 24589266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
    PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy.
    Kalambur VS; Mahaseth H; Bischof JC; Kielbik MC; Welch TE; Vilbäck A; Swanlund DJ; Hebbel RP; Belcher JD; Vercellotti GM
    Am J Hematol; 2004 Oct; 77(2):117-25. PubMed ID: 15389823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease.
    Dalle Carbonare L; Matte' A; Valenti MT; Siciliano A; Mori A; Schweiger V; Zampieri G; Perbellini L; De Franceschi L
    Blood; 2015 Nov; 126(20):2320-8. PubMed ID: 26330244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.
    Kaul DK; Liu XD; Chang HY; Nagel RL; Fabry ME
    J Clin Invest; 2004 Oct; 114(8):1136-45. PubMed ID: 15489961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbated metabolic changes in skeletal muscle of sickle cell mice submitted to an acute ischemia-reperfusion paradigm.
    Chatel B; Messonnier LA; Vilmen C; Bernard M; Pialoux V; Bendahan D
    Clin Sci (Lond); 2018 Oct; 132(19):2103-2115. PubMed ID: 30185507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):546-555. PubMed ID: 29222304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease.
    Kalish BT; Matte A; Andolfo I; Iolascon A; Weinberg O; Ghigo A; Cimino J; Siciliano A; Hirsch E; Federti E; Puder M; Brugnara C; De Franceschi L
    Haematologica; 2015 Jul; 100(7):870-80. PubMed ID: 25934765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatment.
    Pavan AR; Terroni B; Dos Santos JL
    Nitric Oxide; 2024 Aug; 149():7-17. PubMed ID: 38806107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemia-Reperfusion Injury in Sickle Cell Disease: From Basics to Therapeutics.
    Ansari J; Gavins FNE
    Am J Pathol; 2019 Apr; 189(4):706-718. PubMed ID: 30904156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.